6 February, 2013 12:26PM AEDT By Carol Duncan (ABC Local) Source: abc.net.au Assoc Prof Karen Canfell is a researcher with the Lowy Cancer Research Centre at the University of NSW. HPV is her area of expertise. What does she want us to know about HPV and the vaccination program? CAROL DUNCAN: Karen, your area [...]
Continue reading...Thursday, January 10, 2013
Source: www.drbicuspid.com Author: Drbicuspid staff The rising incidence of cancers associated with human papillomavirus (HPV) shows a need to increase HPV vaccination coverage levels, according to a report in the Journal of the National Cancer Institute (January 7, 2013). Despite the decline in cancer death rates in the U.S., the rate of HPV-associated cancers has [...]
Continue reading...Wednesday, May 9, 2012
Source: Los Angeles Times One in every six cancer deaths worldwide is caused by preventable infections, a total of 1.5 million deaths yearly that could be halted by widespread vaccination programs, researchers reported Wednesday. Since 1990, that number has grown by about half a million, suggesting that vaccination programs are losing ground in the battle [...]
Continue reading...Tuesday, May 8, 2012
Source: LA Times States that require vaccination for pertussis, meningitis and tetanus for admission to middle school have a higher vaccination rate than states that do not, but the rate is not nearly as high as one might expect from such a requirement, researchers reported Monday. States that required only that educational materials be sent [...]
Continue reading...Tuesday, March 20, 2012
Source: nytimes.com Author: Rachel Nuwer In 1951, a 4-year-old boy with leukemia contracted chickenpox. His liver and spleen, swollen by the cancer, soon returned to normal, and his elevated blood cell count fell to that of a healthy child. His doctors at the Laboratory of Experimental Oncology in San Francisco were thrilled by his sudden [...]
Continue reading...Sunday, February 26, 2012
Source: www.cmaj.ca/ Author: Laura Eggertson Provinces weighing the merits of implementing the National Advisory Committee on Immunization’s recommendation to offer human papillomavirus (HPV) vaccine to boys and men aged 9–26 are facing a tricky trade-off between benefits and costs. “I think the benefits are there, but the costs are high,” which is a crucial issue [...]
Continue reading...Thursday, December 22, 2011
Source: Jezebel.com A new study argues that vaccinating boys against HPV isn’t the best use of resources, since vaccinating more girls will actually lead to a greater reduction in overall infections. However, there are also political implications to consider. Back in October, I wrote that the rise of HPV-related throat cancer in men was an [...]
Continue reading...Thursday, December 1, 2011
Source: TheNationsHealth.org Vaccination rates for human papillomavirus are lagging for teens, and a complicated web of confusion and misinformation may be to blame, according to public health leaders. Several strains of HPV can cause cervical cancer, and two vaccines, Gardasil and Cervarix, have been shown conclusively to defend against those strains. The Food and Drug [...]
Continue reading...Tuesday, November 29, 2011
Source: National Cancer Institute End-of-trial results from a trial testing Cervarix, a vaccine against human papillomavirus (HPV) types 16 and 18, showed that the vaccine continued to provide substantial protection against cervical precancers 4 years after vaccination. Cervarix provided almost complete protection in young women who had no evidence of exposure to HPV at the [...]
Continue reading...Wednesday, November 9, 2011
Source: Journal of Clinical Oncology Chaturvedi et al,1 analyzing specimens back to 1984, validate the long-held hypothesis that infection with human papillomavirus (HPV) has increased oropharyngeal squamous cell carcinoma (OPSCC) incidence in the US. They find the incidence of OPSCC in men—who have higher risks of both HPV-positive and HPV-negative OPSCC than women—similar to that [...]
Continue reading...
Wednesday, February 6, 2013
0 Comments